Skip to content

Clinical trials

Observational Diabetes Mellitus, Type 2 trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Observational Country / region: Brazil Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20072
20081
20093
20101
20111
20142
20152
20182
20201
20221
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting2
Terminated2
Active, not recruiting2
Not yet recruiting1
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
University of Campinas, Brazil4
University of Sao Paulo General Hospital3
Novo Nordisk A/S2
University of Sao Paulo2
Bayer1
Cline Research Center1
Eli Lilly and Company1
Mannkind Corporation1
Universidade Sao Francisco1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 221
Diabetes Mellitus5
Insulin Resistance4
Diabetes Mellitus, Type 12
Obesity2
Renal Insufficiency, Chronic2
Chronic Periodontitis1
Coronary Disease1
Diabetes, Gestational1
Diabetic Foot1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.